ZA200706807B - Composition containing chitosan for sustained drug release - Google Patents

Composition containing chitosan for sustained drug release

Info

Publication number
ZA200706807B
ZA200706807B ZA200706807A ZA200706807A ZA200706807B ZA 200706807 B ZA200706807 B ZA 200706807B ZA 200706807 A ZA200706807 A ZA 200706807A ZA 200706807 A ZA200706807 A ZA 200706807A ZA 200706807 B ZA200706807 B ZA 200706807B
Authority
ZA
South Africa
Prior art keywords
composition containing
drug release
sustained drug
containing chitosan
chitosan
Prior art date
Application number
ZA200706807A
Inventor
Badwan Adnan
Al-Remawi Mayyas Mohamme Ahmad
Mohammed Murshed Abdel-Qader
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Publication of ZA200706807B publication Critical patent/ZA200706807B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
ZA200706807A 2005-02-17 2005-12-19 Composition containing chitosan for sustained drug release ZA200706807B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05003405A EP1693051B1 (en) 2005-02-17 2005-02-17 Composition containing chitosan for sustained drug release

Publications (1)

Publication Number Publication Date
ZA200706807B true ZA200706807B (en) 2008-10-29

Family

ID=34933799

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706807A ZA200706807B (en) 2005-02-17 2005-12-19 Composition containing chitosan for sustained drug release

Country Status (16)

Country Link
US (1) US20100130612A1 (en)
EP (2) EP1693051B1 (en)
JP (1) JP2008530148A (en)
KR (1) KR20070104643A (en)
CN (1) CN101128183A (en)
AP (1) AP2007004156A0 (en)
AT (1) ATE397439T1 (en)
AU (1) AU2005327852A1 (en)
BR (1) BRPI0520078A2 (en)
CA (1) CA2598364A1 (en)
DE (1) DE602005007319D1 (en)
EA (1) EA200701735A1 (en)
MA (1) MA29317B1 (en)
TN (1) TNSN07288A1 (en)
WO (1) WO2006087028A1 (en)
ZA (1) ZA200706807B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1955693A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Composition comprising chitosan and an acidic drug for oral controlled release
EP1955711A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Composition comprising covalent conjugates of chitosan and an acidic drug for parenteral administration
DE102009024542A1 (en) * 2009-06-10 2010-12-16 Arivine Pharma Ag Compositions based on chitosan oligosaccharides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8608890A1 (en) * 1985-09-16 1986-09-01 Carulla Vekar S A Liquid pharmaceutical preparation based on theophylline with a retarding effect, and process for producing it.
JPH05339149A (en) * 1992-02-27 1993-12-21 Taisho Pharmaceut Co Ltd Sustained release suspension preparation
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
JP3605613B2 (en) * 2001-10-01 2004-12-22 有限会社関西キトサン Liquid for plant cultivation
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition

Also Published As

Publication number Publication date
DE602005007319D1 (en) 2008-07-17
TNSN07288A1 (en) 2008-12-31
MA29317B1 (en) 2008-03-03
CN101128183A (en) 2008-02-20
EP1693051A1 (en) 2006-08-23
BRPI0520078A2 (en) 2009-04-14
EP1848397A1 (en) 2007-10-31
WO2006087028A1 (en) 2006-08-24
US20100130612A1 (en) 2010-05-27
CA2598364A1 (en) 2006-08-24
AU2005327852A1 (en) 2006-08-24
ATE397439T1 (en) 2008-06-15
EA200701735A1 (en) 2008-02-28
JP2008530148A (en) 2008-08-07
EP1693051B1 (en) 2008-06-04
AP2007004156A0 (en) 2007-10-31
KR20070104643A (en) 2007-10-26

Similar Documents

Publication Publication Date Title
IL188964A0 (en) Sustained drug release composition
ZA200705530B (en) Sustained release pharmaceutical formulations
IL190499A0 (en) Sustained release small molecule drug formulation
ZA200710734B (en) Compositions for drug delivery
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
ZA200708705B (en) Pharmaceutical composition
EP1802346A4 (en) Sustained release pharmaceutical composition
HUP0500803A2 (en) Sustained release pharmaceutical preparation containing carvedilol
EP2119442A4 (en) Tacrolimus sustained release pharmaceutical composition
IL189631A0 (en) A controlled release pharmaceutical composition containing hypromellose
EP1937255A4 (en) Pharmaceutical composition
EP1862184A4 (en) Pharmaceutical composition
EP1871348A4 (en) Sustained release pharmaceutical compositions
EP2124959A4 (en) Pharmaceutical composition
PT1909761T (en) Pharmaceutical composition comprising granular pantoprazole
ZA200706807B (en) Composition containing chitosan for sustained drug release
TWI372053B (en) Combination drug
AU2005900624A0 (en) Modified release pharmaceutical composition
GB0505779D0 (en) Drug release system
ZA200800392B (en) Pharmaceutical composition
GB0518166D0 (en) Pharmaceutical composition
GB0511801D0 (en) Pharmaceutical composition
GB0500138D0 (en) Pharmaceutical composition
GB0504276D0 (en) Pharmaceutical composition
ZA200803112B (en) Pharmaceutical composition